ONL Therapeutics

3 followers

‌

ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal diseases and conditions.

Industries

Headquarters

Employees

Links

Org chart

David Esposito

President & CEO

David Esposito

Collapse

David Zacks

Co-Founder & Chief Science Officer

Connie Chang

Chief Operating Officer

Jana Van De Goor

Vice President Development

Amanda Maciel

Director Of Finance

Sushanta Mallick, PhD, MBA

Chief Development Officer

Wen Jing Chen

Chief Operating Officer

Xiao Ting Sun

Chief Operating Officer

Teams

Advisory

5 members

Operations Team

5 members

Leadership Team

4 members

Research and Development

4 members

Similar companies

Ionis Pharmaceuticals

22 followers

Cytokinetics

11 followers

Avantor

10 followers

Charles River Laboratories

9 followers

Schrödinger

8 followers

Sage Therapeutics

4 followers

Merck

195 followers

AbbVie

149 followers

Gritstone Bio

3 followers

Kiniksa Pharmaceuticals

2 followers

Amgen

181 followers

Discover companies